Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors.
作者信息
Li Yangling, Zhou Dongmei, Xu Shuang, Rao Mingjun, Zhang Zuoyan, Wu Linwen, Zhang Chong, Lin Nengming
机构信息
Department of Clinical Pharmacology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou 310006, China.
Department of Clinical Pharmacology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
出版信息
Cancer Biol Med. 2022 May 10;19(7):1109-10. doi: 10.20892/j.issn.2095-3941.2022.0172.
Abstract
摘要
Zotero 插件